Story
AI Wearables Face Privacy Backlash, Threatening Tech's Post-Smartphone Bet

Summary
Technology companies are pushing AI-powered glasses and pins as the next major computing platform, but significant consumer privacy fears and legal challenges could slow adoption and disrupt the multi-billion dollar market.
The technology industry's ambition to create a post-smartphone era with AI-powered wearable devices is facing a significant obstacle: a growing global backlash over privacy. Companies betting on devices that can continuously see, hear, and process the world are now confronting legal scrutiny and public distrust that could hinder the adoption of this emerging technology.
A New Wave of Devices Meets Old Fears
Meta's Ray-Ban smart glasses have become a focal point for the controversy. The device, which pairs EssilorLuxottica's popular frames with Meta's AI, has drawn criticism over fears of covert recording and data misuse. The pushback has been tangible, with some UK venues restricting their use and a U.S. lawsuit alleging the glasses captured private moments that were later reviewed by human annotators to train AI systems.
The lawsuit, filed by the firm Clarkson, claims that recordings of individuals in private situations were uploaded to Meta's servers, contradicting what it calls the company's privacy promises. In response, Meta told Reuters that a non-disablable indicator light protects the privacy of those nearby and that it will contest the lawsuit's allegations, stating that reviewing user data to improve products is a common industry practice with measures to filter identifying information.
Major Players Navigate a Trust Deficit
The privacy debate is shaping the strategies of major tech firms aiming for a piece of the more than $600 billion smartphone market. Amid the controversy, Meta is reportedly expected to unveil camera-free smart glasses, highlighting the delicate balance companies must strike between functionality and public trust. Samsung also plans to enter the market through partnerships but does not currently view the devices as direct smartphone replacements.
AdOpenAI CEO Sam Altman, speaking to journalists in December, articulated a vision for a trusted, always-on device that would ultimately need to process data locally rather than send it to the cloud. "If a device is going to be listening to your whole life and watching your whole life, most people will not want that running on a cloud server," Altman said, acknowledging that achieving this level of local processing may take several more years.
Startups Pivot to Privacy-First Designs
The market's sensitivity to surveillance has created an opening for startups to innovate with privacy-focused designs. These companies are exploring different form factors to reassure consumers:
- Even Realities, a Shenzhen-based startup, has introduced camera-free smart glasses, believing consumers increasingly associate camera-equipped eyewear with surreptitious recording.
- Pocket, a San Francisco firm, is betting on a phone-mounted audio recorder that requires a deliberate button press, making the act of recording more transparent.
- Plaud sells wearable AI recorders, including an earbud system, that alert bystanders with lights or audio announcements when recording is active.
This challenge is not entirely new. Jitesh Ubrani, a research director at IDC, noted that smartphones faced similar unease when cameras and microphones first became ubiquitous. The core issue, he suggests, is not opposition to recording itself but a societal demand for consent and awareness—a hurdle the AI wearables industry must clear to achieve mainstream success.
Read next
More on Stocks
AI Infrastructure Firm Accelevation Sets IPO Terms, Targeting Up to $5.4 Billion Valuation
AI infrastructure provider Accelevation is targeting a valuation of up to $5.37 billion and aims to raise as much as $720 million in its upcoming U.S. initial public offering, capitalizing on strong investor interest in artificial intelligence.

Quest, Labcorp Shares Tumble on Proposed Medicare Reimbursement Cuts
Shares of Quest Diagnostics and Labcorp fell sharply in premarket trading after the Centers for Medicare & Medicaid Services proposed significant cuts to laboratory testing fees, set to begin in 2027.

Roche's Obesity Drug Enicepatide Shows 15.5% Weight Loss in Mid-Stage Diabetes Trial
Swiss drugmaker Roche announced its experimental obesity drug, enicepatide, helped patients with type 2 diabetes achieve an average 15.5% weight loss and significant blood sugar control in a mid-stage study.

DoorDash to Pay $131.5 Million in NYC Settlement Over Worker Pay Issues
Food delivery giant DoorDash has agreed to a $131.5 million settlement with New York City following a probe that found the company underpaid or delayed payments to its delivery workers.